Back
Relmada Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison
Sell
27
RLMD
Relmada Therapeutics
Last Price:
$0.36
Seasonality Move:
8.98%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Sell
27
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy, Sell or Hold?
-
The current Relmada Therapeutics [RLMD] share price is $0.36. The Score for RLMD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RLMD Stock Price Chart
What is Relmada Therapeutics's stock price today?
-
The Relmada Therapeutics share price today is $0.36Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
RLMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.71 | Sell |
Relative Strength Index (14 RSI): | 17.01 | Sell |
Chaikin Money Flow: | 36672 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.36 - 2.86) | Sell |
Bollinger Bands (100): | (1.8 - 3.76) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 19.69 | Sell |
Chaikin Money Flow: | 20899665 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.63 - 110.99) | Sell |
Bollinger Bands (100): | (107.27 - 131.41) | Sell |
RLMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.37 | Sell |
20-day SMA: | 1.29 | Sell |
50-day SMA: | 2.53 | Sell |
200-day SMA: | 3.35 | Sell |
8-day EMA: | 0.47 | Sell |
20-day EMA: | 1.12 | Sell |
50-day EMA: | 2.06 | Sell |
200-day EMA: | 3.13 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.71 | Sell |
20-day SMA: | 106.65 | Sell |
50-day SMA: | 109.28 | Sell |
200-day SMA: | 126.25 | Sell |
8-day EMA: | 102.07 | Sell |
20-day EMA: | 105.53 | Sell |
50-day EMA: | 110.02 | Sell |
200-day EMA: | 118.09 | Sell |
Relmada Therapeutics Earnings Growth & RLMD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.41 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.
Relmada Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |